Update on the CNS adverse effects of Sustiva (efavirenz).
Punwani
Kiron
K
Suedkamp
Shannon
S
Nguyen
Diem
D
Song
Jessica C
JC
D000293:Adolescent; D000328:Adult; D000480:Alkynes; D048588:Benzoxazines / Q000009:adverse effects* / Q000493:pharmacokinetics; D002490:Central Nervous System / Q000187:drug effects*; D003521:Cyclopropanes; D005260:Female; D006801:Humans; D044382:Population Groups; D011358:Product Surveillance, Postmarketing; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics; D014481:United States; D014486:United States Food and Drug Administration
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz